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Introduction
Running from 2010-2013, the “European surveillance 
network for influenza in pigs (ESNIP) 3”
(http://www.esnip3.eu/index.html) represents the only 
organised surveillance network for influenza in pigs in 
Europe and seeks to strengthen formal interactions with 
human and avian surveillance networks. 
Materials and Methods
The project consortium comprises 24 participants, 
contributing a variety of specialities and skills ensuring 
multi-disciplinary cutting-edge outputs. Among them, 
15 partners are actively involved in swine influenza (SI) 
surveillance. Three work packages aim to increase 
knowledge of the epidemiology and evolution of SI 
virus (SIV) in European pigs to inform changes in 
disease trends and variation in contemporary viruses 
through organised field surveillance programmes. 
During the first year of the project, activities focused on 
the exchange of surveillance systems and 
standardisation and validation of methods. An inventory 
of virological and serological surveillance systems has 
been organised through a questionnaire.
To confirm that all participating laboratories were 
capable of detecting all relevant SIV subtypes, a PCR 
ring trial was arranged. The panel consisted of 17 
positive samples, 9 negative samples, and 2 ‘lures’
(decoys) – and was sent to 12 participating partners for 
detection of positive samples.
In order to validate and calibrate the performance of the 
selected HI protocol to be used for preliminary 
antigenic subtyping, a standard panel of five sera and 
antigens was prepared and sent for testing to four 
laboratories.
Results
An inventory of the surveillance programmes that are 
currently active in the participating countries , showed 
that passive surveillance was being (or will be) used in 
most cases.
Selected virus isolates from the different countries have 
been collected and curated in a central virus bank at 
AHVLA, UK. These isolates are presently subjected to 
detailed antigenic (HI assay characterisation using swine 
hyperimmune monospecific sera and antigenic 
cartography) and genomic (full genome sequencing)
characterisation. Data derived from surveillance 
activities have been merged. Briefly, in most countries 
the European subtypes avian-like (av)H1N1, the 2009 
pandemic variant H1N1 (H1N1pdm09), H1N2 and 
H3N2 constituted the dominating subtypes in 2011. 
H1N1pdm09 viruses were isolated at an increasing 
prevalence in some countries, likely indicating that this 
subtype has become established in the swine population. 
In contrast, the H3N2 subtype has not been isolated in 
some geographic areas whereas it was prevalent in other 
parts of Europe.
Twelve partners participated in the PCR ring trial and 
the results showed that every laboratory employs
diagnostic tests capable of detecting all relevant 
circulating SIV subtypes, including the H1N1pdm09
virus. Some differences in sensitivity and specificity 
were seen among the participating labs, depending on 
the assays used.
Reference panel testing by HI assay in four laboratories 
revealed small differences in obtained titers, but in 
general the consistency among the laboratories was
good, and the panels were provided to partners. 
Conclusions and Discussion
The activities of the ESNIP 3 project will improve SI 
diagnosis by updating reagents employed in the 
recommended techniques. These approaches will aid 
pandemic preparedness and planning for human 
influenza whilst providing an evidence base for 
decisions relating to veterinary health.  This work was 
supported by the ESNIP 3 project (Grant #259949,
headed by Prof. IH Brown; AHVLA, UK).
